Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
03/2014
03/12/2014CN103626848A Solid-phase synthetic method of Halipeptin Orfamide A
03/12/2014CN103626847A Wheat germ protein source zinc phytochelatin and preparation method thereof
03/12/2014CN103626846A Ligand polypeptide specifically combined with MDSCs (Myeloid-Derived Suppressor Cells) and drug delivery system
03/12/2014CN103145803B Polypeptide in specific binding with breast cancer brain metastases cells
03/12/2014CN102775474B Polypeptide and applications thereof
03/12/2014CN102741272B Peptides inhibiting adhesion of aspergillus fumigatus to cornea
03/12/2014CN102643334B Polypeptide molecule for serum in gastric cancer and application
03/12/2014CN102584947B Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
03/12/2014CN102286076B Preparation method for bivalirudin
03/12/2014CN102229650B High purity lipopeptides, lipopeptide micelles and processes for preparing same
03/12/2014CN101921310B Dengue virus (DENV) specific HLA-A2 (Human Leukocyte Antigen-A2) restrictive epitope peptide and application thereof
03/12/2014CN101641114B Treatment of inflammation and/or endotoxic shock
03/12/2014CN101501063B Polymyxin derivatives and uses thereof
03/11/2014US8669348 Anti diabetic protein
03/11/2014US8669346 Bone marrow targeting peptides
03/11/2014US8669345 Nogo receptor antagonists
03/11/2014US8669231 Activation of peptide prodrugs by hK2
03/11/2014US8669230 Immunogenic epitopes for immunotherapy
03/11/2014US8669226 Antimicrobial compositions and methods of use thereof
03/11/2014US8669046 Reagents and methods for detecting influenza virus proteins
03/11/2014CA2396428C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
03/06/2014WO2014035345A1 Peptides and uses thereof
03/06/2014WO2014035179A1 Mitochondrial targeting peptide
03/06/2014WO2014034922A1 Peptide for inhibiting vascular endothelial growth factor receptor
03/06/2014WO2014034754A1 Psf1-derived peptide
03/06/2014WO2014034669A1 Lipid membrane structure including bacterial cell component having dispersibility in non-polar solvent, and method for producing same
03/06/2014WO2014032782A1 Jagaricin derivatives and their use as fungicide or antitumor agent
03/06/2014WO2014032257A1 Method for preparing bivalirudin
03/06/2014WO2014001229A3 Cell penetrating peptides & methods of identifying cell penetrating peptides
03/06/2014US20140066594 Binding ligand linked drug delivery conjugates of tubulysins
03/06/2014US20140066593 Process for a folate-targeted agent
03/06/2014US20140066384 Novel genes and proteins that home to developing microvessels
03/06/2014US20140066381 Novel peptides that are modulators of the protein trf2 and compositions containing same
03/06/2014US20140066375 Pharmaceutical composition containing an endocytic motif and protein transduction domains for preventing or treating cancer
03/06/2014US20140066361 Peptides and use thereof in the inhibition of angiotensin converting enzyme
03/06/2014US20140065176 T-cell death-inducing epitopes
03/06/2014US20140065175 Carrier peptides for cell delivery
03/06/2014US20140065152 Novel epitope for switching to th1 cell and use thereof
03/06/2014DE112012001839T5 Caspofungin oder Salze davon mit hoher Reinheit sowie Herstellungsverfahren und Verwendung dafür Caspofungin or salts thereof having high purity and preparation method and use it
03/05/2014EP2703410A1 Jagaricin, derivatives, and uses thereof
03/05/2014EP2703409A1 Intermediate for synthesizing caspofungin and preparation method therefor
03/05/2014EP2703014A1 Synthetic vitreous material
03/05/2014EP2702068A1 Aptamer -modified polymeric materials for the binding of therapeutic factors in a wound environment
03/05/2014EP2701726A1 Novel polypeptides and use thereof
03/05/2014CN103613645A Antioxidant peptide sourced from limnonectes fragilis as well as gene and application thereof
03/05/2014CN103613644A Small peptide lactotransferrin (LTF) with anti-tumor effect and application thereof
03/05/2014CN103613643A Bioactive small peptide, synthesis method and use thereof as animal feed additive
03/05/2014CN103613642A Liquid-phase segmented synthesis method of argireline
03/05/2014CN101899098B Preparation of cyclic lipopeptide compound Maribasin B and application thereof
03/05/2014CN101880316B Human RBPMS polypeptide and preparation method of antibody thereof
03/04/2014US8664369 LH liquid formulations
03/04/2014US8664356 Gamma amino acid building blocks
03/04/2014US8664355 Cell-free protein synthesis method with the use of linear template DNA and cell extract therefor
03/04/2014US8664181 Dual acting prodrugs
03/04/2014US8663603 Multivalent constructs for therapeutic and diagnostic applications
02/2014
02/27/2014WO2014029816A1 Anti-c1q epitope elisa
02/27/2014WO2014028997A1 Synthetic pntx(19) peptide, pharmaceutical compositions and use
02/27/2014US20140058061 Process for preparing platinum-carbene complexes
02/27/2014US20140057857 Cross-Linked Peptides and Proteins, Methods of Making Same, and Uses Thereof
02/27/2014US20140057853 Treatment of Cancers with A-8R Peptide
02/27/2014US20140057852 Treatment of Cancers with A-8R Peptide
02/27/2014US20140057833 Adiponectin receptor agonists and methods of use
02/27/2014US20140057831 Anti-fibrotic peptides and their use in methods for treating diseases and disorders characterized by fibrosis
02/27/2014US20140057828 Small Peptide Modulators of Potassium Channel Trafficking
02/27/2014US20140057320 Method for Preparing Cyclic Lipopeptide Compound
02/27/2014US20140056871 Anti-inflammatory antibodies and uses therefor
02/27/2014US20140056847 Inhibitors of serine proteases
02/26/2014EP2699584A1 Cyclic peptide from nonomuraea sp., process for the production thereof, and pharmaceutical composition for the prevention or treatment of mycobacteria related disease comprising the same
02/26/2014EP2699327A1 Method for purification of micafungin
02/26/2014CN103601792A Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
02/26/2014CN102746381B Helicobacter pylori antigen HLA restrictive immunodominance epitope peptide and preparation method and application thereof
02/26/2014CN102276698B MC4-R cyclopeptide agonist and application thereof
02/26/2014CN101932592B Antitumoral compounds
02/25/2014US8658763 Amphiphilic peptides and hydrogel matrices thereof for bone repair
02/25/2014US8658762 Polypeptides that inhibit dopamine D2 receptor-DISC1 interaction and methods of use thereof
02/25/2014US8658601 Peptides and nanoparticles for therapeutic and diagnostic applications
02/25/2014US8658594 Peptide inhibitors of protein kinase C
02/25/2014CA2532869C Novel peptidic conjugates for alopecia preventive and curative treatment
02/25/2014CA2507936C Prion protein ligands and methods of use
02/25/2014CA2451310C Antimicrobial peptides
02/20/2014WO2014028011A1 Anti-microbial activity of synthetic peptides
02/20/2014WO2014027652A1 Method and device for biomolecule analysis using raman spectroscopy
02/20/2014WO2014026277A1 Method for identifying novel minor histocompatibility antigens
02/20/2014US20140051843 Methods and compositions for detecting promoter activity and expressing fusion proteins
02/20/2014US20140051647 Synthetic peptide that induces expression of tnf receptor 2 and use thereof
02/20/2014US20140051628 Composition for long-acting peptide analogs
02/20/2014US20140051145 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
02/20/2014US20140051096 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
02/20/2014US20140050793 Novel Compositions for Inhibiting Virus Entry and Promoting Virolysis, and Methods Thereof
02/20/2014US20140050775 Polyamine Derivatives
02/20/2014US20140050751 Mesothelin Vaccines and Model Systems
02/20/2014US20140050749 MHC-I Restricted Epitopes Containing Non-Natural Amino Acid Residues
02/20/2014US20140050739 Local complement inhibition for treatment of complement-mediated disorders
02/20/2014US20140050662 Prostate specific antigen agents and methods of using same for prostate cancer imaging
02/19/2014EP2698635A2 Methods and compositions for targeting sites of neovascular growth
02/19/2014EP2698376A1 Cancer-targeting peptides and uses thereof in cancer therapy
02/19/2014EP2697246A1 Selective cysteine protease inhibitors and uses thereof
02/19/2014CN103596969A Peptides that modulate complex saspase-flg2
02/19/2014CN103590116A Low-cost high throughput screening method of antibacterial peptide lead compound
02/19/2014CN103586092A Immobilisation of chelating groups for immobilised metal ion chromatography (IMAC)
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 423